title: In vivo and in silico analyses of estrogenic potential of bisphenol analogs in medaka (Oryzias latipes) and common carp (Cyprinus carpio).
abstract: Various studies have demonstrated the estrogenic effect of bisphenol A (BPA), a member of bisphenol analogs (BPs), in in vitro and in vivo assays. However, limited data are available on the estrogenic potentials and risks of other BPs in aquatic organisms. In addition, the estrogenic effect of chemicals is known to have species-specific responses in teleost fish. The objective of this study was to evaluate the potential estrogenic effects of BPs on the medaka (Oryzias latipes) and common carp (Cyprinus carpio) using in vivo and in silico assays. Our quantitative real-time PCR analyses revealed that the expression levels of several hepatic estrogen-responsive biomarker genes in male medaka responded to various types and concentrations of BPs in a dose-response manner. The order of in vivo estrogenic potencies of BPs was as follows: BPC≈BPAF>BPB>BPA⋙BPP. To further investigate the interaction potential of BPs with medaka estrogen receptor α (ERα) in silico, a three-dimensional model of the ERα ligand-binding domain (LBD) was built and docking simulations were performed. The docking simulation analysis revealed that BPC interaction potential for medaka ERα LBD was the most potent, followed by BPAF and BPA. Comparing this with carp ERα LBD revealed that the interaction potentials of these BPs to medaka ERα LBD were more stable than to carp ERα LBD. Furthermore, we identified key amino acid residues in medaka ERα LBD that interacted with BPC (Glu356, Arg397, and Cys533), BPAF (Thr350 and Glu356), and BPA (Glu356 and Met424), and found some differences in these key amino acid residues between medaka and carp ERα LBDs. These results of in vivo and in silico analyses showed potential estrogenic effects of BPs in teleost fish, and they also indicated that the differences in interaction potentials and key amino acid residues between medaka and carp ERα LBDs may be due to the differences between the species and estrogenic potencies of the selected BPs.
authors.affiliation: Department of Chemical and Biological Engineering, Ariake National College of Technology, 150 Higashi-hagio-machi, Omuta, Fukuoka 836-8585, Japan.
authors.forename: Akemi
authors.initials: A
authors.lastname: Yamaguchi
authors.affiliation: Faculty of Agriculture, Ehime University, 3-5-7 Tarumi, Matsuyama 790-8566, Japan. Electronic address: hiroishi@agr.ehime-u.ac.jp.
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Ishibashi
authors.affiliation: Faculty of Environmental and Symbiotic Sciences, Prefectural University of Kumamoto, 3-1-100 Tsukide, Kumamoto 862-8502, Japan.
authors.forename: Koji
authors.initials: K
authors.lastname: Arizono
authors.affiliation: Department of Chemical and Biological Engineering, Ariake National College of Technology, 150 Higashi-hagio-machi, Omuta, Fukuoka 836-8585, Japan. Electronic address: tominaga@ariake-nct.ac.jp.
authors.forename: Nobuaki
authors.initials: N
authors.lastname: Tominaga
mesh_terms: D000596:Amino Acids / Q000737:chemistry; D000818:Animals; D001559:Benzhydryl Compounds / Q000633:toxicity*; D002347:Carps / Q000378:metabolism*; D047628:Estrogen Receptor alpha / Q000235:genetics / Q000378:metabolism; D004967:Estrogens / Q000633:toxicity*; D005506:Food Contamination / Q000032:analysis; D005819:Genetic Markers; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008297:Male; D009990:Oryzias / Q000378:metabolism*; D010636:Phenols / Q000633:toxicity*; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D015854:Up-Regulation; D014819:Vitellogenins / Q000235:genetics / Q000378:metabolism; D000098826:Bisphenol A Compounds
chemical_list: D000596:Amino Acids; D001559:Benzhydryl Compounds; D047628:Estrogen Receptor alpha; D004967:Estrogens; D005819:Genetic Markers; D010636:Phenols; D012333:RNA, Messenger; D014819:Vitellogenins; C442419:estrogen receptor alpha, medaka; C006780:bisphenol A; D000098826:Bisphenol A Compounds
keywords: Bisphenol analogs; Choriogenin; Docking simulation; Estrogen receptor α; Vitellogenin